BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND CCDC6, D10S170, 8030, ENSG00000108091, Q16204, TPC, H4, TST1 AND Prognosis
12 results:

  • 1. VISTA and PD-L1 synergistically predict poor prognosis in patients with extranodal natural killer/T-cell lymphoma.
    He HX; Gao Y; Fu JC; Zhou QH; Wang XX; Bai B; Li PF; Huang C; Rong QX; Ping LQ; He YX; Mao JY; Chen X; Huang HQ
    Oncoimmunology; 2021 Apr; 10(1):1907059. PubMed ID: 33889438
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Expression of co-inhibitory molecules B7-H4 and B7-H1 in Epstein-Barr virus positive diffuse large B-cell lymphoma and their roles in tumor invasion.
    Jiang Y; Lin J; Zhang J; Lu S; Wang C; Tong Y
    Pathol Res Pract; 2019 Dec; 215(12):152684. PubMed ID: 31679792
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Novel B7-H4-mediated crosstalk between human non-Hodgkin lymphoma cells and tumor-associated macrophages leads to immune evasion via secretion of IL-6 and IL-10.
    Che F; Heng X; Zhang H; Su Q; Zhang B; Chen Y; Zhang Z; Du Y; Wang L
    Cancer Immunol Immunother; 2017 Jun; 66(6):717-729. PubMed ID: 28246881
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. PI3K/mTOR inhibition markedly potentiates HDAC inhibitor activity in NHL cells through BIM- and MCL-1-dependent mechanisms in vitro and in vivo.
    Rahmani M; Aust MM; Benson EC; Wallace L; Friedberg J; Grant S
    Clin Cancer Res; 2014 Sep; 20(18):4849-60. PubMed ID: 25070836
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. RET, ROS1 and ALK fusions in lung cancer.
    Takeuchi K; Soda M; Togashi Y; Suzuki R; Sakata S; Hatano S; Asaka R; Hamanaka W; Ninomiya H; Uehara H; Lim Choi Y; Satoh Y; Okumura S; Nakagawa K; Mano H; Ishikawa Y
    Nat Med; 2012 Feb; 18(3):378-81. PubMed ID: 22327623
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Vorinostat-induced apoptosis in mantle cell lymphoma is mediated by acetylation of proapoptotic BH3-only gene promoters.
    Xargay-Torrent S; López-Guerra M; Saborit-Villarroya I; Rosich L; Campo E; Roué G; Colomer D
    Clin Cancer Res; 2011 Jun; 17(12):3956-68. PubMed ID: 21652541
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Histone H4 acetylation by immunohistochemistry and prognosis in relapsed acute lymphocytic leukaemia (ALL).
    Advani AS; Gibson S; Douglas E; Diacovo J; Elson P; Kalaycio M; Copelan E; Sekeres M; Sobecks R; Sungren S; Lagoo A; Rizzieri D; Hsi E
    Br J Haematol; 2011 May; 153(4):504-7. PubMed ID: 21375525
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Histone H4 acetylation by immunohistochemistry and prognosis in newly diagnosed adult acute lymphoblastic leukemia (ALL) patients.
    Advani AS; Gibson SE; Douglas E; Jin T; Zhao X; Kalaycio M; Copelan E; Sobecks R; Sekeres M; Sungren S; Hsi ED
    BMC Cancer; 2010 Jul; 10():387. PubMed ID: 20663136
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma.
    Vidulich KA; Talpur R; Bassett RL; Duvic M
    Int J Dermatol; 2009 Mar; 48(3):243-52. PubMed ID: 19261011
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Somatic hypermutation and B-cell lymphoma.
    Dunn-Walters D; Thiede C; Alpen B; Spencer J
    Philos Trans R Soc Lond B Biol Sci; 2001 Jan; 356(1405):73-82. PubMed ID: 11205334
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Prognostic significance of tumor burden in the blood of patients with erythrodermic primary cutaneous T-cell lymphoma.
    Scarisbrick JJ; Whittaker S; Evans AV; Fraser-Andrews EA; Child FJ; Dean A; Russell-Jones R
    Blood; 2001 Feb; 97(3):624-30. PubMed ID: 11157477
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Cell volumes of normal and malignant mononuclear cells.
    Chapman EH; Kurec AS; Davey FR
    J Clin Pathol; 1981 Oct; 34(10):1083-90. PubMed ID: 6975780
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.